Concomitant oral drugs and nutrients in the gastrointestinal lumen (DNI)

Concomitant oral drugs and nutrients in the gastrointestinal lumen refers to the physiological and chemical environment where drug-food interactions (DFIs) occur during the process of digestion and absorption [StatPearls: Drug-Food Interactions]. This is not a discrete molecular target such as a receptor or enzyme, but rather a pharmacokinetic context that significantly influences the bioavailability and efficacy of orally administered medications [PubMed: PMC2728931]. Within the gastrointestinal lumen, nutrients can interact with drugs through various mechanisms, including physical complexation or chelation (e.g., tetracyclines with calcium), alterations in gastric pH, and changes in gastrointestinal motility or gastric emptying rates [FDA: Drug-Food Interactions]. Furthermore, dietary components can compete for or modulate the activity of intestinal transporters, such as P-glycoprotein, and metabolic enzymes, like Cytochrome P450 3A4, located in the enterocytes [PubMed: PMC7071205]. These interactions can lead to therapeutic failure due to decreased absorption or potential toxicity due to increased systemic exposure, making the management of drug-nutrient timing a critical aspect of clinical pharmacology and patient safety.

Other names

Drug-food interactionsDrug-nutrient interactionsFood-effectLuminal drug-nutrient interactions

Mechanisms include physical chelation or complexation of drugs with minerals, alteration of gastric pH affecting drug solubility, competition for intestinal transporters like P-glycoprotein, and modulation of enterocyte metabolic enzymes such as CYP3A4 [FDA; PubMed: PMC7071205].